v3.26.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Cash Flows From Operating Activities:    
Net loss $ (1,793,381) $ (2,256,930)
Adjustments to reconcile net loss to net cash used in operating activities:    
Stock-based compensation 55,872 153,891
Fair value option loss on convertible notes 344,000
Change in fair value of equity payable 28,171
Change in fair value of warrant liabilities (16,000)
Changes in operating assets and liabilities:    
Prepaid expenses and other current assets (92,374) (313,905)
Vendor deposits 14,484
Accounts payable 111,885 191,445
Deferred offering costs 8,386
Accrued expenses and other current liabilities 548,225 445,061
Net Cash Used In Operating Activities (799,118) (1,772,052)
Cash Flows From Financing Activities:    
Proceeds from issuance of convertible notes and warrants 1,000,000
Private placement of warrants 1,999,791
Registration and issuance costs associated with warrant issuance (147,131)
Net Cash Provided By Financing Activities 1,000,000 1,852,660
Net Increase in Cash 200,882 80,608
Cash - Beginning of Period 101,778 1,530,924
Cash - End of Period 302,660 1,611,532
Supplemental Disclosures of Cash Flow Information:    
Interest
Income taxes
Non-cash investing and financing activities:    
Warrant modification - incremental value 53,890
Private placement costs reflected in accounts payable and accrued expenses $ 76,561 $ 135,718